Navigation Links
AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008
Date:10/3/2008

TUSTIN, Calif., Oct. 3 /PRNewswire-FirstCall/ -- (http://www.amdl.com) AMDL, Inc. (Amex: ADL), a leading vertically integrated bio-pharmaceutical company with major operations in China and the US, today announced that the Company will present at the Maxim Group Growth Investor Conference in New York City on Tuesday, October 7, 2008 at 10:30 a.m. ET. AMDL's presentation will be held at the Grand Hyatt New York Hotel in the Morosco Room.

The Maxim Group Growth Conference features interactive presentations and one-on-one meetings with executives from over 80 emerging growth companies within various sectors including healthcare and pharmaceuticals. Attendees include securities analysts, fund managers and institutional investors.

AMDL, Inc. is a specialty pharmaceutical Company devoted to the research, development, manufacturing, and marketing of over 180 diagnostic, pharmaceutical, nutritional supplement, and cosmetic products in China and outlying markets.

This year alone, the Company has secured over $25 million in sales contracts for its best-selling Goodnak(R) anti-aging product; expanded the Goodnak(R) revenue opportunity with the launch of two additional product formulations that include Goodnak(R) capsules and Goodnak(R) lotions; and secured US FDA clearance on July 3, 2008 for its ELISA DR-70(R) FDP cancer diagnostic test - the first test to be cleared by the US FDA in over 25 years for the monitoring of colorectal cancer.

These are a few milestones AMDL's Board Chairman and Audit Committee Chair Mr. Douglas MacLellan will highlight in a presentation which will also cover AMDL's market opportunity as an aggressively growing micro-cap investment opportunity in t
'/>"/>

SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor
2. Rudd Report Highlights AMDL, Inc.s Latest Business Achievements; Supports 2008 Financial Guidance
3. The Wall Street Transcript Interviews AMDL, Inc. CEO & President Gary Dreher for Fall Healthcare Issue
4. AMDL, Inc. Closes Private Placement of Convertible Notes
5. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
6. Avicena Group to Present at Noble Financial Conference
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. CEL-SCI to Present at the Noble Financial Conference
11. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... NEW YORK , September 2, 2014 ... Market Study on Membrane Technology in Pharmaceutical, Biopharma and ... Witness Highest Growth by 2019" the global membrane technology market for ... 7,029.9 million in 2014 and is expected to grow ... to reach an estimated value of USD 10,886.0 million ...
(Date:9/2/2014)... 2014 Myriant Corporation, a global ... a distribution agreement with Azelis Group, a specialty ... bio-succinic acid in the Nordics, Benelux, France, Iberia, ... in the industrial and base chemicals markets. , ... a far-reaching chemical portfolio with extensive distribution networks ...
(Date:9/2/2014)...  Xencor, Inc. (NASDAQ: XNCR ), ... for the treatment of autoimmune diseases, asthma and ... of Debra Zack , M.D., Ph.D., vice ... Lloyd Rowland , senior vice president, chief compliance ... expertise in biologics clinical development and medical affairs ...
(Date:9/2/2014)... , Sept. 2, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" ... million. The orders consist of three large odour control systems ... . "These orders are consistent with the market ... Peter Bruijns , President and CEO. "After a difficult period ... are now beginning to see sales growth. Our lower cost ...
Breaking Biology Technology:Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 3Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 4Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 5Myriant and Azelis Sign European Distribution Agreement for Bio-Succinic Acid 2Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 2Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 3
... in third quarter 2008; up 40% year-to-date , ... goodwill impairment charge , , ... Inc. (Nasdaq: ENCO ) , a full service ... countries for many of the world,s leading pharmaceutical and ...
... this years, most unique must-have gift , ... New York, NY(PRWEB) November ... from the customers, DNA, launch DNA Mini Portraits™, a more affordable line ... DNA Minis are the most personal and unique gifting solution for this ...
... Zounds Hearing, a unique manufacturing,and retail company ... point and professional service, announces the introduction of,assistive ... all who are hard of,hearing. The various devices ... Hearing,Centers retail locations effective November 24, 2008. ...
Cached Biology Technology:Encorium Reports Third Quarter 2008 Financial Results 2Encorium Reports Third Quarter 2008 Financial Results 3Encorium Reports Third Quarter 2008 Financial Results 4Encorium Reports Third Quarter 2008 Financial Results 5Encorium Reports Third Quarter 2008 Financial Results 6Encorium Reports Third Quarter 2008 Financial Results 7Encorium Reports Third Quarter 2008 Financial Results 8Encorium Reports Third Quarter 2008 Financial Results 9DNA 11, Creators of DNA Art, Introduces a More Affordable Line of Custom Portraits for this Year's Gift Giving Season 2Zounds Offers the Gift of Hearing This Holiday Season With a Range of New Products 2
(Date:9/2/2014)... September 2, 2014 In a new study that ... the Florida campus of The Scripps Research Institute (TSRI) ... into unique manufacturing sites for molecules that can treat ... cell as a reaction vessel and a disease-causing defect ... diseased cell," said TSRI Professor Matthew Disney.,"Because the treatment ...
(Date:9/2/2014)... sequence their genetic information. How is it possible ... parts of the body are so different? While every ... additional regulatory layer exists that determines which of the ... modifications of genome-bound histone proteins or the DNA itself ... top of the genetic information and is thus called ...
(Date:9/2/2014)... issue of The FASEB Journal , ... the leading cause of blindness in adults, diabetic ... advance involves quantifying the early molecular changes caused ... Using new probes developed by scientists, they were ... diabetic retinopathy. , "My goal is to establish ...
Breaking Biology News(10 mins):Scripps Florida scientists make diseased cells synthesize their own drug 2Throwing a loop to silence gene expression 2Molecular probes permit doctors to detect diabetic retinopathy before vision fails 2
... and other insects to flap their wings, jump and ... in an article in the journal ACS Macro ... a protein called resilin in nanosprings, biorubbers, biosensors and ... scientists discovered resilin a half-century ago in the wing ...
... deep underground could at the same be used to release ... thus offsetting some of the environmental impact of burning fossil ... peer-reviewed International Journal of Oil, Gas and Coal Technology ... previously untapped fossil fuel reserves has been in the headlines ...
... don,t expect to catch the flute-like song of a Veery ... hoots, and is singing much less to ensure that it ... by Kenneth Schmidt of Texas Tech University and Kara Loeb ... journal Behavioral Ecology and Sociobiology , provides insights into ...
Cached Biology News:Sequestration and fuel reserves 2Veeries very quiet when owls are about 2
... is a 10.0 kb Autographa californica (AcNPV) ... the AcNPV polyhedrin promoter and two AcNPV ... is a Sma I cloning site, followed ... this,an inverted polyhedrin promoter has been inserted ...
... a mixture of Strep•Tag® II fusion proteins ... markers provide precise size references for proteins ... blue. Because each of the proteins contains ... also be detected by the Strep•Tag II ...
... The UltraRocker rocking platform, 120 V, is ... overnight incubation of liquid cultures, staining and destaining ... rocker features variable speed control (8-40 rpm) and ... (10 lb). The rocker features two 29 x ...
...
Biology Products: